Posts

Showing posts with the label market access
Show all
Image

EU Joint Clinical Assessment after the first reports: How should companies interpret the findings?

Image

England’s Single National Formulary: Win-Win Reform or New Market Access Bottleneck?

Image

MASH in 2025: New Therapies, New Challenges

Image

China’s NRDL: The World’s Largest Market Access Event Is Underway

Image

Most-Favored-Nation Drug Pricing: Policy Shift or Pressure Tactic?

Image

EU HTA is now live: what do we do now?

Image

Changes in Market Access in Europe and Implications for Clinical Development Planning: Joint Clinical Assessments